N-acetylcysteine in the treatment of non-alcoholic steatohepatitis.

Suppr

超能文献

作者信息

Pamuk Gülsüm Emel, Sonsuz Abdullah

出版信息

J Gastroenterol Hepatol. 2003 Oct;18(10):1220-1. doi: 10.1046/j.1440-1746.2003.03156.x.

DOI:10.1046/j.1440-1746.2003.03156.x

PMID:12974918

Abstract

摘要

相似文献

N-acetylcysteine in the treatment of non-alcoholic steatohepatitis.

J Gastroenterol Hepatol. 2003 Oct;18(10):1220-1. doi: 10.1046/j.1440-1746.2003.03156.x.

Two cases from the spectrum of nonalcoholic steatohepatitis.

J Clin Gastroenterol. 1995 Mar;20(2):127-30. doi: 10.1097/00004836-199503000-00011.

Effects of N-acetylcysteine on oxidative stress in rats with non-alcoholic steatohepatitis.

J Med Assoc Thai. 2007 Apr;90(4):788-97.

Is non-alcoholic steatohepatitis another facet of the bright liver syndrome?

Ital J Gastroenterol. 1996 Apr;28(3):187.

Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study.

Aliment Pharmacol Ther. 2001 Oct;15(10):1667-72. doi: 10.1046/j.1365-2036.2001.01083.x.

Non-alcoholic steatohepatitis.

Lancet. 1999 Oct 9;354(9186):1300. doi: 10.1016/S0140-6736(05)76072-4.

[Treatment of non-alcoholic steatohepatitis (NASH). A comparative study of ursodeoxycholic acid and alpha-tocopherol. A preliminary report].

Rev Gastroenterol Mex. 2002 Apr-Jun;67(2):70-5.

[Pathological and clinical analysis of nonalcoholic steatohepatitis].

Zhonghua Gan Zang Bing Za Zhi. 2003 Jun;11(6):384.

Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis.

Am J Gastroenterol. 1987 Jul;82(7):650-4.

[Non-alcoholic steatohepatitis: natural history and diagnosis].

Gastroenterol Clin Biol. 2003 Aug-Sep;27(8-9):793-8.

引用本文的文献

Comprehensive transcriptomic analysis and meta-analysis identify therapeutic effects of N-acetylcysteine in nonalcoholic fatty liver disease.

Front Pharmacol. 2023 May 15;14:1186582. doi: 10.3389/fphar.2023.1186582. eCollection 2023.

Addressing the liver progenitor cell response and hepatic oxidative stress in experimental non-alcoholic fatty liver disease/non-alcoholic steatohepatitis using amniotic epithelial cells.

Stem Cell Res Ther. 2021 Jul 28;12(1):429. doi: 10.1186/s13287-021-02476-6.

Role of -Acetylcysteine in the Treatment of Acute Nonacetaminophen, Nonalcoholic and Nonviral Hepatitis: A Meta-analysis.

J Can Assoc Gastroenterol. 2020 Jul 15;4(3):125-130. doi: 10.1093/jcag/gwaa017. eCollection 2021 Jun.

N-Acetyl Cysteine Targets Hepatic Lipid Accumulation to Curb Oxidative Stress and Inflammation in NAFLD: A Comprehensive Analysis of the Literature.

Antioxidants (Basel). 2020 Dec 16;9(12):1283. doi: 10.3390/antiox9121283.

The Potential Use of Metabolic Cofactors in Treatment of NAFLD.

Nutrients. 2019 Jul 12;11(7):1578. doi: 10.3390/nu11071578.

Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis.

Nutrients. 2016 Jun 28;8(7):397. doi: 10.3390/nu8070397.

Glutathione!

Integr Med (Encinitas). 2014 Feb;13(1):8-12.

Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease.

World J Hepatol. 2015 Mar 27;7(3):559-65. doi: 10.4254/wjh.v7.i3.559.

Nonalcoholic Fatty liver disease: pathogenesis and therapeutics from a mitochondria-centric perspective.

Oxid Med Cell Longev. 2014;2014:637027. doi: 10.1155/2014/637027. Epub 2014 Oct 13.

Probiotics and Nonalcoholic Fatty liver Disease.

Middle East J Dig Dis. 2013 Jul;5(3):129-36.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验